Concepedia

Albert DeFelice

AD

Statistics

Publications

7

Citations

894

H-Index

7

Active since

1975

Affiliations

United States Food and Drug Administration(Current)

Novartis (Switzerland)

Sterling Research Group (United States)

Albert DeFelice is an author at United States Food and Drug Administration specializing in medicine, urology, and nephrology.

Top concepts

Publications per year

1975–2013

7

Publications

7

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

Frank Dieterle, Frank D. Sistare, Federico Goodsaid et al. · Nature Biotechnology · 2010 · 403 citations

, , +9

3,4-Diphenyl-1H-pyrazole-1-propanamine antidepressants

Denis M. Bailey, Philip E. Hansen, Allan G. Hlavac et al. · Journal of Medicinal Chemistry · 1985 · 301 citations

Regulatory Considerations for Oligonucleotide Drugs: Updated Recommendations for Pharmacology and Toxicology Studies

Lauren E. Black, James G. Farrelly, JOY A. CAVAGNARO et al. · Antisense Research and Development · 1994 · 61 citations

Anticipated Classes of New Medications and Molecular Targets for Pulmonary Arterial Hypertension

Nicholas W. Morrell, Stephen L. Archer, Albert DeFelice et al. · Pulmonary Circulation · 2013 · 46 citations · Full text

Time course of hemodynamic changes in rats with healed severe myocardial infarction

Albert DeFelice, Richard Frering, Patrick Horan · American Journal of Physiology-Heart and Circulatory Physiology · 1989 · 46 citations

, , +19

1–5 of 7